AEON Biopharma, Inc. (AEON)
NYSEAMERICAN: AEON · Real-Time Price · USD
0.3221
-0.1610 (-33.33%)
At close: Jul 13, 2026, 4:00 PM EDT
0.4583
+0.1362 (42.29%)
After-hours: Jul 13, 2026, 8:00 PM EDT
AEON Biopharma Market Cap
AEON Biopharma has a market cap or net worth of $8.47 million as of July 13, 2026. Its market cap has decreased by -1.74% in one year.
Market Cap
8.47M
Enterprise Value
9.09M
1-Year Change
-1.74%
Ranking
Category
Stock Price
$0.32
Market Cap Chart
Since April 12, 2021, AEON Biopharma's market cap has decreased from $63.66M to $8.47M, a decrease of -86.69%. That is a compound annual growth rate of -31.87%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 13, 2026 | 8.47M | -34.93% |
| Dec 31, 2025 | 13.02M | -39.67% |
| Dec 31, 2024 | 21.58M | -91.93% |
| Dec 29, 2023 | 267.55M | -80.82% |
| Dec 30, 2022 | 1.40B | 553.24% |
| Dec 30, 2021 | 213.58M | 235.51% |
| Apr 12, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cocrystal Pharma | 13.93M |
| Lunai Bioworks | 13.33M |
| IN8bio | 13.10M |
| BioLineRx | 13.08M |
| Intensity Therapeutics | 12.92M |
| Chemomab Therapeutics | 12.53M |
| CytoMed Therapeutics | 12.19M |
| Moleculin Biotech | 12.17M |